---
title: "莱佛士医疗集团回购了更多股份"
description: "莱佛士医疗集团在新加坡证券交易所当天发布的文件中表示，周三以 SG$199,260 回购了 200,000 股，平均每股 SG$0.995。该医疗服务提供商目前已在其现有授权下回购了 510 万股"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/232541003.md"
published_at: "2025-03-20T08:20:39.000Z"
---

# 莱佛士医疗集团回购了更多股份

> 莱佛士医疗集团在新加坡证券交易所当天发布的文件中表示，周三以 SG$199,260 回购了 200,000 股，平均每股 SG$0.995。该医疗服务提供商目前已在其现有授权下回购了 510 万股

根据新加坡证券交易所当天的公告，莱佛士医疗集团在周三以 199,260 新元的价格回购了 200,000 股，单价为 0.995 新元。

该医疗服务提供商目前已根据其现有授权回购了 510 万股。

### Related Stocks

- [BSL.SG - 莱佛士医疗](https://longbridge.com/zh-CN/quote/BSL.SG.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Raffles Medical Group: Solid Balance Sheet and Earnings Inflection Underscore Attractive Entry Point | Analyst Wee Kuang Tay of CGS-CIMB has reiterated a Buy rating on Raffles Medical Group with a price target of S$1.23, ci | [Link](https://longbridge.com/zh-CN/news/271645484.md) |
| AgelessRx Expands Access to Multi-Cancer Early Detection Solutions, in Honor of Cancer Prevention Month | AgelessRx is expanding access to its multi-cancer early detection solutions in honor of Cancer Prevention Month. This in | [Link](https://longbridge.com/zh-CN/news/276180967.md) |
| Xsolis Announces the Appointment of Vic Pierni as Chief Financial Officer | Xsolis has appointed Vic Pierni as Chief Financial Officer. Pierni, a CPA with over 25 years of experience in financial  | [Link](https://longbridge.com/zh-CN/news/276187646.md) |
| Physitrack Intends To Implement Share Buyback Program | Physitrack PLC :BOARD APPROVES INTENTION TO IMPLEMENT SHARE BUYBACK PROGRAMTO REPURCHASE UP TO 10% OF ISSUED SHARE CAPIT | [Link](https://longbridge.com/zh-CN/news/276423338.md) |
| ZAWYA-PRESSR: Frimex acquires 60% stake in Gulf Neo Care to establish a strategic healthcare platform in Saudi Arabia | Frimex International Investment Company has acquired a 60% stake in Gulf Neo Care, a Saudi firm specializing in neonatal | [Link](https://longbridge.com/zh-CN/news/276105068.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。